enVVeno Medical
NVNO
3 hedge funds and large institutions have $240K invested in enVVeno Medical in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.51% more ownership
Funds ownership: 1.11% → 1.61% (+0.51%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
2% less capital invested
Capital invested by funds: $244K → $240K (-$4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$141K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10K |
NVNO Hedge Fund Activity: Q2 2019 in Review
3 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2019, worth a combined $240K — down 1.6% from $244K a quarter earlier.
Fund positioning in NVNO was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $141K. The largest seller was UBS Group, exiting entirely with an estimated $10K sold.
- 3 institutional investors held enVVeno Medical (NVNO) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $240K of enVVeno Medical stock for Q2 2019, down 1.6% quarter-over-quarter.
- 1 fund opened new enVVeno Medical positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest enVVeno Medical buyer in Q2 2019 was Jane Street, an estimated $141K added.
- The largest enVVeno Medical seller in Q2 2019 was UBS Group, an estimated $10K sold.
Based on aggregated 13F filings for Q2 2019.